WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
about
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic ReviewManagement of multidrug-resistant TB: novel treatments and their expansion to low resource settingsEmerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?Drug-resistant tuberculosis in Eastern Europe: challenges and ways forwardEuropean union standards for tuberculosis careHIV and tuberculosis--science and implementation to turn the tide and reduce deathsExtensively drug-resistant tuberculosis: epidemiology and managementAlternative methods of diagnosing drug resistance--what can they do for me?Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysisStrategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosisTuberculosis: epidemiology and controlDrug therapy in spinal tuberculosisFactors that influence current tuberculosis epidemiologyCrystal structure of Mycobacterium tuberculosis ketol-acid reductoisomerase at 1.0 Å resolution - a potential target for anti-tuberculosis drug discoveryControlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infectionInfection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the KeyIs there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungsUse of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic reviewMultidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristicsLinkage of presumptive multidrug resistant tuberculosis (MDR-TB) patients to diagnostic and treatment services in CambodiaAggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortalityLow resistance to first and second line anti-tuberculosis drugs among treatment naive pulmonary tuberculosis patients in southwestern Uganda.Development and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South AfricaAntituberculosis Drug Resistance Survey in Lesotho, 2008-2009: Lessons LearnedHigh Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South AfricaTuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South AfricaThe Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey"My Favourite Day Is Sunday": Community Perceptions of (Drug-Resistant) Tuberculosis and Ambulatory Tuberculosis Care in Kara Suu District, Osh Province, KyrgyzstanPropensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant TuberculosisNew anti-tuberculosis drugs and regimens: 2015 updateCombined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.Comparison of TaqMan(®) Array Card and MYCOTB(TM) with conventional phenotypic susceptibility testing in MDR-TB.Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases.World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory.Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.
P2860
Q24202081-43BAC024-4F48-4C6A-B184-DC8568D6BCACQ26764847-9B277A0C-1A99-463C-BDDF-8802E5FCE523Q26765394-BFE13558-A332-4513-8E77-BD7475390B20Q26771997-243843B4-165E-4EFF-BBA3-9DADF1806521Q26782448-E5D102C9-A46E-4C86-BD08-7AA28091A765Q26823223-2DF6313C-4A87-4149-816A-D23BF23A5F4DQ26824501-3F23EFE8-B005-4601-91DD-66D188DD5D17Q26830094-82C0DD64-1616-4FCC-9D80-CEEABABA8213Q26852644-14EA2970-7E33-4648-BAD1-3D70D9966B7AQ26999537-F8BBA602-C6A1-4AAC-B84F-F46DC7FBA870Q27003186-00D0A70E-C4B5-4415-809F-3171E02374A2Q27021104-4A796014-023A-4C3A-B2D8-DAB06B3D8A08Q27022999-1C934CFC-5C23-48F8-88C9-666F1A70AAF5Q27025298-19BC398C-6148-4258-9E86-910BE61AA5A5Q27704017-E657006E-9ACD-4912-8798-9F0FEA7C11E7Q28087385-3753AF73-AFDB-4CE9-BB6D-47104CB09457Q28393098-8F73334E-31A6-4BEE-AF87-0D9D6F0F89E7Q28393235-6A3D731B-D523-4F3D-936E-A4961A65A2EBQ28396228-70B13679-B74E-4CF4-9CA1-851808B3A518Q28484857-6736BA2D-34EB-4242-B5D8-AB4097A4A028Q28484917-2B79BB34-DC1C-4B0E-AEF9-ADED73D9B0A0Q28487078-A370FC1F-F175-4393-BE1B-B64DE3B273A7Q28487938-E078A38F-D762-445F-8433-46C1DD3E6850Q28543362-AC4C36CB-4CDC-47B3-9572-8F6E6D3C2F01Q28545021-D832CE37-48D0-4D9D-B93E-E8348558F68FQ28546755-12C2DFC9-743E-4ABA-B590-604FD128CEC8Q28547703-5457C5C2-AB8D-4538-89B2-A799AE4BCDD3Q28550587-D5A8108F-7289-4CB8-BABF-21CDB56C44BEQ28550944-4DBC12CF-5752-450E-A631-CB308B25339BQ28551011-BDCE7A06-285F-442E-B68C-718A678D22B0Q28551033-1A82CF3A-245C-4C47-A207-C71E3AC71C04Q28596775-3A83599F-20F9-4267-98B8-C6D94153F061Q30236048-120B0159-1A2F-4876-BBDD-7C361E951799Q30275673-0E837270-A5D7-4CA7-8A02-CE12BF418F58Q30276393-07B3A991-9033-4AD1-8E52-DF851EB7D21EQ30376781-3B31077F-0F15-4EB9-AD76-EC98D9EFFB38Q30377488-37407AFB-C801-4B69-9529-BEBE867548DEQ30408918-7C5081CB-29DA-44ED-960F-DA1F1393712DQ30414792-D0D02B0B-39A9-4E70-81FC-55FFC130891FQ30573127-CA1932F1-026C-4EF1-AB99-16468324AA66
P2860
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
description
im August 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 04 August 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2011
@uk
name
WHO guidelines for the program ...... tant tuberculosis: 2011 update
@en
WHO guidelines for the program ...... tant tuberculosis: 2011 update
@nl
type
label
WHO guidelines for the program ...... tant tuberculosis: 2011 update
@en
WHO guidelines for the program ...... tant tuberculosis: 2011 update
@nl
prefLabel
WHO guidelines for the program ...... tant tuberculosis: 2011 update
@en
WHO guidelines for the program ...... tant tuberculosis: 2011 update
@nl
P2093
P50
P1476
WHO guidelines for the program ...... tant tuberculosis: 2011 update
@en
P2093
A Salakaia
C D Mitnick
C Duncombe
C Fitzpatrick
C Lienhardt
P304
P356
10.1183/09031936.00073611
P577
2011-08-04T00:00:00Z